Goncalves Joana — SEC Form 4 filings
SEC reporting owner CIK 1756991. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-05 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 38 legs across 13 filings — 86,351 shares, $4,552,786 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 44.
- Largest priced transaction: sale of 3,320 shares @ $112.01 ($371,886) in Oruka Therapeutics, Inc., filed 2026-08-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Chief Medical Officer | 12 | — | 35 legs · 72,535 sh · $4,543,452 | 43 |
| Cara Therapeutics, Inc. (CARA) | CHIEF MEDICAL OFFICER | 4 | — | 3 legs · 13,816 sh · $9,334 | 1 |
Form 4 filings — Goncalves Joana
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 2,384 @ $91.10 · Sale (S): 3,150 @ $92.03 · Sale (S): 1,366 @ $92.99 · Sale (S): 100 @ $94.22 · +3 more | EDGAR |
| 2026-08-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 900 @ $109.65 · Sale (S): 300 @ $110.52 · Sale (S): 3,320 @ $112.01 · Sale (S): 2,480 @ $112.56 · +2 more | EDGAR |
| 2026-07-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 400 @ $84.36 · Sale (S): 2,497 @ $85.86 · Sale (S): 3,803 @ $86.68 · Sale (S): 300 @ $87.25 · +2 more | EDGAR |
| 2026-06-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 1,636 @ $68.38 · Sale (S): 5,064 @ $69.42 · Sale (S): 300 @ $70.62 · Sale (S): 947 @ $69.69 · +2 more | EDGAR |
| 2026-05-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 4,800 @ $61.56 · Sale (S): 2,100 @ $62.42 · Sale (S): 100 @ $63.52 · Option exercise (M): 3,500 (derivative) @ $0 · +1 more | EDGAR |
| 2026-04-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 4,227 @ $65.73 · Sale (S): 2,273 @ $66.56 · Sale (S): 500 @ $67.38 · Option exercise (M): 3,500 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 2,921 @ $40.11 · Sale (S): 2,902 @ $41.20 · Sale (S): 1,177 @ $41.94 · Sale (S): 641 @ $41.30 · +2 more | EDGAR |
| 2026-02-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 6,064 @ $32.30 · Sale (S): 936 @ $32.78 · Option exercise (M): 3,500 (derivative) @ $0 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 32,500 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 4,381 @ $31.56 · Sale (S): 2,619 @ $32.24 · Option exercise (M): 3,500 (derivative) @ $0 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 641 @ $28.53 · Sale (S): 1,787 @ $29.62 · Sale (S): 1,492 @ $30.70 · Sale (S): 3,080 @ $31.58 · +2 more | EDGAR |
| 2025-01-24 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 162,500 (derivative) @ $0 | EDGAR |
| 2024-04-09 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,753 @ $0.83 | EDGAR |
| 2024-03-04 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 3,293 @ $0.89 | EDGAR |
| 2024-02-12 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 7,770 @ $0.53 | EDGAR |
| 2024-02-05 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 13,500 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1756991 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →